
FDA Conditionally Approves First Drug to Manage Acute Pancreatitis in Dogs

WASHINGTON — The Food and Drug Administration has conditionally approved Panoquell-CA1 for the management of clinical signs associated with acute onset of pancreatitis in dogs.
Panoquell-CA1 is an injectable drug intended for use while the dog is hospitalized for treatment of the disease.
Pancreatitis is a painful inflammatory disease of the pancreas that can be life-threatening and generally requires that dogs be hospitalized for treatment. In most cases, it occurs spontaneously.
Common factors that increase the chance of developing pancreatitis include when dogs eat something outside of their normal diet (particularly fatty foods), treatment with certain medications, and diseases like diabetes mellitus, the FDA said.
It is more common in certain breeds of dogs and in some dogs may become a recurring or chronic condition.
“This is the first drug to address a serious and life-threatening disease that previously could only be managed through supportive care, such as intravenous fluids, pain medication, antiemetics, and dietary rest,” said Steven M. Solomon, D.V.M., M.P.H., director of the FDA’s Center for Veterinary Medicine, in a written statement.
“The conditional approval pathway allows medications like Panoquell-CA1 to reach the marketplace more quickly, and in this case gives dogs suffering from acute onset of pancreatitis earlier access to a drug to manage this disease,” he said.
Conditional approval means that, when used according to the label, the drug is safe and has a reasonable expectation of effectiveness.
The initial conditional approval is valid for one year with the potential for four annual renewals.
During this time, the animal drug sponsor – in this case Ishihara Sangyo Kaisha Ltd. – must demonstrate active progress toward proving substantial evidence of effectiveness for full approval.
If the sponsor does not meet the requirements for substantial evidence of effectiveness at the conclusion of five years, the product can no longer be marketed.
Fuzapladib sodium, the active ingredient in Panoquell, has been approved since 2018 in Japan to improve clinical signs in the acute phase of pancreatitis in dogs, but not in the United States until Tuesday.
The FDA reviewed data associated with fuzapladib’s use in Japan as part of its assessment of the application for conditional approval.
The agency said veterinarians should advise owners about the possible side effects, which include loss of appetite, digestive tract disorders, respiratory tract disorders, liver disease and jaundice, before using the drug.
It is also encouraging dog owners to work with their veterinarian to report any adverse events or side effects potentially related to the use of any drug, including Panoquell-CA1.
Dan can be reached at [email protected] and at https://twitter.com/DanMcCue
In The News
Health
Voting
Regulation
WASHINGTON — President Joe Biden is urging Congress to give the Federal Deposit Insurance Corporation more power to punish bank... Read More
WASHINGTON — President Joe Biden is urging Congress to give the Federal Deposit Insurance Corporation more power to punish bank executives whose institutions failed due their own mismanagement or excessive risk taking. Biden’s remarks, issued as a statement from the White House, come in the wake... Read More
ATCHAFALAYA NATIONAL WILDLIFE REFUGE, La. (AP) — Stacks of valves, networks of pipes and hulking, two-story-tall tanks litter parts of... Read More
ATCHAFALAYA NATIONAL WILDLIFE REFUGE, La. (AP) — Stacks of valves, networks of pipes and hulking, two-story-tall tanks litter parts of the swampy landscape of Louisiana’s Atchafalaya Basin, rusting relics of sites where oil wells were drilled in the 1970s, an unwanted legacy of the energy industry... Read More
WASHINGTON — For the first time, the Environmental Protection Agency is proposing federal limits on toxic “forever chemicals” in drinking... Read More
WASHINGTON — For the first time, the Environmental Protection Agency is proposing federal limits on toxic “forever chemicals” in drinking water, a move the Biden administration believes will prevent serious illness and death for thousands of Americans each year. PFAS, an abbreviation for perfluoroalkyl and polyfluoroalkyl... Read More
NEW YORK (AP) — President Joe Biden on Monday told U.S. residents the nation’s financial systems are sound, following the... Read More
NEW YORK (AP) — President Joe Biden on Monday told U.S. residents the nation’s financial systems are sound, following the swift and stunning collapse of two banks that prompted fears of a broader upheaval. “Americans can have confidence that the banking system is safe,” he said... Read More
WASHINGTON — Sens. Joe Manchin, D-W.Va., and Mike Braun, R-Ind., reintroduced a trio of bills Wednesday aimed at reforming how... Read More
WASHINGTON — Sens. Joe Manchin, D-W.Va., and Mike Braun, R-Ind., reintroduced a trio of bills Wednesday aimed at reforming how the Food and Drug Administration approves and manages opioid medications. “In the last year, more than 106,000 Americans and 1,400 West Virginians died from drug-related overdoses,”... Read More
WASHINGTON — The Food and Drug Administration has approved the first combination test for flu and COVID-19 that can be... Read More
WASHINGTON — The Food and Drug Administration has approved the first combination test for flu and COVID-19 that can be used at home. The test from Lucira Health, which can be purchased without a prescription, can detect influenza A and B, commonly known as the flu,... Read More